Covered recipient · General Payments record
VI T DUONG
Allopathic & Osteopathic Physicians Obstetrics & Gynecology Urogynecology and Reconstructive Pelvic Surgery
General Payments · PY2021–2024
$3,751.87
- Reported across 42 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,426.90 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Axonics Modulation Technologies, Inc. | $842.30 | 10 |
| BOSTON SCIENTIFIC CORPORATION | $335.28 | 4 |
| COLOPLAST CORP | $157.21 | 2 |
| Medtronic, Inc. | $92.11 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Axonics, Inc. | $120.89 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142363519 | CMS |
| Axonics, Inc. | $167.03 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142363537 | CMS |
| Axonics, Inc. | $130.12 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142363569 | CMS |
| Axonics, Inc. | $12.78 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142363633 | CMS |
| Axonics, Inc. | $15.74 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142363635 | CMS |
| Axonics, Inc. | $147.88 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142363615 | CMS |
| Axonics, Inc. | $73.85 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142363637 | CMS |
| Axonics, Inc. | $13.06 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142363655 | CMS |
| Axonics, Inc. | $17.19 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142363643 | CMS |
| Axonics, Inc. | $143.76 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142363663 | CMS |
| Boston Scientific Corporation | $16.30 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092549597 | CMS |
| Boston Scientific Corporation | $154.86 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092549601 | CMS |
| Boston Scientific Corporation | $110.04 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092549599 | CMS |
| Boston Scientific Corporation | $54.08 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092549515 | CMS |
| COLOPLAST CORP | $63.23 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117463511 | CMS |
| COLOPLAST CORP | $93.98 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117463509 | CMS |
| Medtronic, Inc. | $92.11 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119279258 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.